The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

The US FDA approved an RSV vaccine called Arexvy. How effective is it, when will it be available, and who can take it? CNN Medical Analyst Dr. Leana Wen explains.

In addition to RSV, the seasonal spike in flu and COVID-19 infections could create “tripledemic” conditions that can easily overwhelm emergency rooms, clinics and other health-care providers.

A vaccine to protect against severe cases of Respiratory Syncytial Virus could roll out as early as August. Pfizer has developed RSVpreF, a vaccine to prevent severe cases of RSV, and the Food and ...

Moderna's respiratory syncytial virus, or RSV, vaccine for older adults was about 84% effective at preventing serious illness, according to data from a late-stage trial published Tuesday.. Adult ...

The vaccine, first approved in May, comes after an especially tough RSV season. The CDC estimates 80,000 children younger than 5 as well as 160,000 older adults were hospitalized due to ...